Skip to main content

Find Clinical Trials

Home
Conditions
Togaviridae Infections

Clinical trial condition

Togaviridae Infections

Explore clinical trials studying Togaviridae Infections. Study availability and eligibility vary by location and protocol.

147 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Togaviridae Infections trial results

Completed

A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)

NCT04514107

Conditions: Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +12 more
Locations: Universidade Federal de Minas Gerais, Instituto de Ciencias Biologicas, Department of Biochemistry and Immunology Belo Horizonte, Minas Gerais, Brazil

View Trial Details

Completed

Quantifying the Epidemiological Impact of Targeted Indoor Residual Spraying on Aedes-borne Diseases

NCT04343521

Conditions: Aedes-borne Diseases, Alphavirus Infections, Arbovirus Infections, +14 more
Locations: Universidad Autonoma de Yucatan Mérida, Yucatán, Mexico

View Trial Details

Completed

Spatial Repellents for Aedes-borne Virus Control in Sri Lanka

NCT05452447

Conditions: Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +11 more
Locations: Epidemiology Unit, Ministry of Health Colombo, West, Sri Lanka

Clinical Trials Unit Ragama, West, Sri Lanka

View Trial Details

Completed

Immunogenicity of Japanese Encephalitis Vaccine Co-administered With Measles-Mumps-Rubella Vaccine (MMR)

NCT06331702

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +31 more
Locations: Jiangsu Provincial Center for Disease Control and Prevention Nanjing, Jiangsu, China

View Trial Details

Completed

Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age

NCT03071575

Conditions: Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations: Icddr,B Chāndpur, Bangladesh

View Trial Details

Completed

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

NCT05630846

Conditions: Chickenpox, DNA Virus Infections, Herpesviridae Infections, +19 more
Locations: GSK Investigational Site Birmingham, Alabama, United States

GSK Investigational Site Jonesboro, Arkansas, United States

GSK Investigational Site Bellflower, California, United States

GSK Investigational Site Huntington Park, California, United States

View all 47 locations

View Trial Details

Completed

Impact of Differential and Systematic Diagnosis of Dengue, Chikungunya and Malaria on Patient Management and Antibiotic Use in West Africa

NCT06257810

Conditions: Alphavirus Infections, Arbovirus Infections, Chikungunya, +17 more
Locations: Institut de Recherche en Sciences de la Santé Ouagadougou, Burkina Faso

CHU Cocody Abidjan, Cocody, Côte d’Ivoire

CHU Treichville Abidjan, Treichville, Côte d’Ivoire

View Trial Details

Completed

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

NCT05349617

Conditions: Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations: Suncoast Research Associates, LLC Miami, Florida, United States

Panax Clinical Research Miami Lakes, Florida, United States

Global Clinical Research Professionals (GCP) St. Petersburg, Florida, United States

AMR Kansas City Kansas City, Missouri, United States

View Trial Details

Completed

Phase 2 Open-label Study of Alum-adjuvanted Chikungunya Virus-like Particle Vaccine (PXVX0317)

NCT03992872

Conditions: Alphavirus Infections, Arbovirus Infections, Chikungunya, +7 more
Locations: United States Army Medical Research Institute of Infectious Diseases Fort Deterick, Maryland, United States

Walter Reed Army Institute of Research Silver Spring, Maryland, United States

View Trial Details

Completed

A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)

NCT05072080

Conditions: Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations: Optimal Research, LLC Huntsville, Alabama, United States

Alliance for Multispecialty Research - Mobile Mobile, Alabama, United States

Alliance for Multispecialty Research, LLC Tempe, Arizona, United States

Velocity Clinical Research, Banning Banning, California, United States

View all 47 locations

View Trial Details